147 related articles for article (PubMed ID: 15065610)
1. Potential effects of fluticasone propionate on bone mineral density in patients with asthma: a 2-year randomized, double-blind, placebo-controlled trial.
Kemp JP; Osur S; Shrewsbury SB; Herje NE; Duke SP; Harding SM; Faulkner K; Crim CC
Mayo Clin Proc; 2004 Apr; 79(4):458-66. PubMed ID: 15065610
[TBL] [Abstract][Full Text] [Related]
2. Comparable effects of inhaled fluticasone propionate and budesonide on the HPA-axis in adult asthmatic patients.
Ringdal N; Lundbäck B; Alton M; Rak S; Eivindson A; Bratten G; Kjaersgaard P
Respir Med; 2000 May; 94(5):482-9. PubMed ID: 10868712
[TBL] [Abstract][Full Text] [Related]
3. Diskus and diskhaler: efficacy and safety of fluticasone propionate via two dry powder inhalers in subjects with mild-to-moderate persistent asthma.
Galant SP; van Bavel J; Finn A; Gross G; Pleskow W; Brown A; Hamedani AG; Harding SM
Ann Allergy Asthma Immunol; 1999 Mar; 82(3):273-80. PubMed ID: 10094218
[TBL] [Abstract][Full Text] [Related]
4. Fluticasone propionate powder and lack of clinically significant effects on hypothalamic-pituitary-adrenal axis and bone mineral density over 2 years in adults with mild asthma.
Li JT; Ford LB; Chervinsky P; Weisberg SC; Kellerman DJ; Faulkner KG; Herje NE; Hamedani A; Harding SM; Shah T
J Allergy Clin Immunol; 1999 Jun; 103(6):1062-8. PubMed ID: 10359887
[TBL] [Abstract][Full Text] [Related]
5. Effects of the inhaled corticosteroids fluticasone propionate, triamcinolone acetonide, and flunisolide and oral prednisone on the hypothalamic-pituitary-adrenal axis in adult patients with asthma.
Sorkness CA; LaForce C; Storms W; Lincourt WR; Edwards L; Rogenes PR
Clin Ther; 1999 Feb; 21(2):353-67. PubMed ID: 10211538
[TBL] [Abstract][Full Text] [Related]
6. Effects of fluticasone propionate, triamcinolone acetonide, prednisone, and placebo on the hypothalamic-pituitary-adrenal axis.
Li JT; Goldstein MF; Gross GN; Noonan MJ; Weisberg S; Edwards L; Reed KD; Rogenes PR
J Allergy Clin Immunol; 1999 Apr; 103(4):622-9. PubMed ID: 10200011
[TBL] [Abstract][Full Text] [Related]
7. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.
Pearlman DS; Stricker W; Weinstein S; Gross G; Chervinsky P; Woodring A; Prillaman B; Shah T
Ann Allergy Asthma Immunol; 1999 Mar; 82(3):257-65. PubMed ID: 10094216
[TBL] [Abstract][Full Text] [Related]
8. Fluticasone propionate in children with moderate asthma.
Hoekstra MO; Grol MH; Bouman K; Stijnen T; Köeter GH; Kauffman HF; Gerritsen J
Am J Respir Crit Care Med; 1996 Oct; 154(4 Pt 1):1039-44. PubMed ID: 8887604
[TBL] [Abstract][Full Text] [Related]
9. Effects of budesonide by means of the Turbuhaler on the hypothalmic-pituitary-adrenal axis in asthmatic subjects: a dose-response study.
Aaronson D; Kaiser H; Dockhorn R; Findlay S; Korenblat P; Thorsson L; Källén A
J Allergy Clin Immunol; 1998 Mar; 101(3):312-9. PubMed ID: 9525445
[TBL] [Abstract][Full Text] [Related]
10. Nocturnal cortisol secretion in asthmatic patients after inhalation of fluticasone propionate.
Weiner P; Berar-Yanay N; Davidovich A; Magadle R
Chest; 1999 Oct; 116(4):931-4. PubMed ID: 10531155
[TBL] [Abstract][Full Text] [Related]
11. Fluticasone propionate powder: oral corticosteroid-sparing effect and improved lung function and quality of life in patients with severe chronic asthma.
Nelson HS; Busse WW; deBoisblanc BP; Berger WE; Noonan MJ; Webb DR; Wolford JP; Mahajan PS; Hamedani AG; Shah T; Harding SM
J Allergy Clin Immunol; 1999 Feb; 103(2 Pt 1):267-75. PubMed ID: 9949318
[TBL] [Abstract][Full Text] [Related]
12. Inhaled fluticasone propionate delivered by means of two different multidose powder inhalers is effective and safe in a large pediatric population with persistent asthma.
Peden DB; Berger WE; Noonan MJ; Thomas MR; Hendricks VL; Hamedani AG; Mahajan P; House KW
J Allergy Clin Immunol; 1998 Jul; 102(1):32-8. PubMed ID: 9679845
[TBL] [Abstract][Full Text] [Related]
13. Effect of fluticasone propionate aqueous nasal spray versus oral prednisone on the hypothalamic-pituitary-adrenal axis.
Vargas R; Dockhorn RJ; Findlay SR; Korenblat PE; Field EA; Kral KM
J Allergy Clin Immunol; 1998 Aug; 102(2):191-7. PubMed ID: 9723660
[TBL] [Abstract][Full Text] [Related]
14. Comparative efficacy and safety of twice daily fluticasone propionate powder versus placebo in the treatment of moderate asthma.
Pearlman DS; Noonan MJ; Tashkin DP; Goldstein MF; Hamedani AG; Kellerman DJ; Schaberg A
Ann Allergy Asthma Immunol; 1997 Apr; 78(4):356-62. PubMed ID: 9109702
[TBL] [Abstract][Full Text] [Related]
15. Systemic effects of inhaled fluticasone propionate and budesonide in adult patients with asthma.
Derom E; Van Schoor J; Verhaeghe W; Vincken W; Pauwels R
Am J Respir Crit Care Med; 1999 Jul; 160(1):157-61. PubMed ID: 10390394
[TBL] [Abstract][Full Text] [Related]
16. The comparison of the effects of fluticasone propionate and budesonide on clinical indices and on bone mineral density in the asthmatic patients: a one year treatment study.
Harmanci E; Ak I; Ozdemir N; Vardareli E; Elbek O; Uçgun I
Allergol Immunopathol (Madr); 1999; 27(6):298-303. PubMed ID: 10611554
[TBL] [Abstract][Full Text] [Related]
17. A 12-week dose-ranging study of fluticasone propionate powder in the treatment of asthma.
Wasserman SI; Gross GN; Schoenwetter WF; Munk ZM; Kral KM; Schaberg A; Kellerman DJ
J Asthma; 1996; 33(4):265-74. PubMed ID: 8707781
[TBL] [Abstract][Full Text] [Related]
18. Comparison of once- and twice-daily dosing of fluticasone propionate 200 micrograms per day administered by diskus device in patients with asthma treated with or without inhaled corticosteroids.
Wolfe J; Rooklin A; Grady J; Munk ZM; Stevens A; Prillaman B; Duke S; Harding S
J Allergy Clin Immunol; 2000 Jun; 105(6 Pt 1):1153-61. PubMed ID: 10856150
[TBL] [Abstract][Full Text] [Related]
19. Fluticasone propionate compared with theophylline for mild-to-moderate asthma.
Galant SP; Lawrence M; Meltzer EO; Tomasko M; Baker KA; Kellerman DJ
Ann Allergy Asthma Immunol; 1996 Aug; 77(2):112-8. PubMed ID: 8760776
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of inhaled fluticasone propionate in asthma results from topical and not from systemic activity.
Lawrence M; Wolfe J; Webb DR; Chervinsky P; Kellerman D; Schaumberg JP; Shah T
Am J Respir Crit Care Med; 1997 Sep; 156(3 Pt 1):744-51. PubMed ID: 9309988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]